Sales outlook
The outlook will show how quickly Novartis expects drug sales to recover from generic competition.
Novartis reports its Q4 FY2026 results on 3 February 2027, before the market opens. Analysts expect earnings per share of 2.23 USD and revenue of 14.65B USD.
In Q3 FY2026, reported on 27 October 2026, Novartis earned 2.46 USD a share against the 2.25 USD analysts expected (+9.3%), on revenue of 14.52B USD against 14.53B USD (-0.1%).
| Period | Report date | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth | Next-day move |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2.23 | — | — | +9.85% | 14.65B | — | — | +9.83% | — | |
| Q3 FY2026 | 2.25 | 2.46 | +9.33% | +9.33% | 14.53B | 14.52B | -0.07% | +1.14% | +2.0% | |
| Q2 FY2026 | 2.17 | 2.41 | +11.06% | -0.41% | 14.07B | 14.41B | +2.43% | +0.90% | +2.9% | |
| Q1 FY2026 | 2.11 | 1.99 | -5.69% | -12.72% | 13.44B | 13.11B | -2.42% | -3.72% | +0.9% | |
| Q4 FY2025 | 1.99 | 2.03 | +2.01% | +2.53% | 13.70B | 13.34B | -2.69% | -1.64% | +2.1% | |
| Q3 FY2025 | 2.26 | 2.25 | -0.44% | +9.22% | 13.64B | 14.36B | +5.25% | +9.00% | -4.3% | |
| Q2 FY2025 | 2.38 | 2.42 | +1.68% | +22.84% | 13.94B | 14.28B | +2.47% | +14.13% | -3.3% | |
| Q1 FY2025 | 2.12 | 2.28 | +7.55% | +26.67% | 13.90B | 13.62B | -2.01% | +15.14% | +0.7% | |
| Q4 FY2024 | 1.80 | 1.98 | +10.00% | +29.41% | 12.84B | 13.56B | +5.61% | +15.13% | -0.1% | |
| Q3 FY2024 | 1.94 | 2.06 | +6.19% | +18.39% | 12.76B | 13.17B | +3.20% | +8.93% | -4.4% | |
| Q2 FY2024 | 1.89 | 1.97 | +4.23% | +7.65% | 12.54B | 12.51B | -0.23% | -10.22% | -4.1% | |
| Q1 FY2024 | 1.73 | 1.80 | +4.05% | +5.26% | 11.44B | 11.83B | +3.40% | -10.44% | +2.3% | |
| Q4 FY2023 | 1.64 | 1.53 | -6.71% | +1.32% | 11.88B | 11.78B | -0.91% | -10.02% | -4.0% | |
| Q3 FY2023 | 1.70 | 1.74 | +2.35% | +10.13% | 12.42B | 12.09B | -2.61% | -5.84% | +0.2% | |
| Q2 FY2023 | 1.68 | 1.83 | +8.93% | +17.31% | 13.47B | 13.94B | +3.43% | +6.50% | +4.6% | |
| Q1 FY2023 | 1.55 | 1.71 | +10.32% | +17.12% | 12.72B | 13.21B | +3.86% | +3.07% | +3.4% | |
| Q4 FY2022 | 1.42 | 1.51 | +6.34% | +7.86% | 13.22B | 13.09B | -1.00% | -3.22% | -2.6% | |
| Q3 FY2022 | 1.57 | 1.58 | +0.64% | -7.60% | 12.88B | 12.84B | -0.33% | -3.93% | +0.9% | |
| Q2 FY2022 | 1.51 | 1.56 | +3.31% | -6.02% | 12.88B | 13.09B | +1.59% | -1.57% | +4.0% | |
| Q1 FY2022 | 1.44 | 1.46 | +1.39% | -3.95% | 12.62B | 12.81B | +1.55% | +0.95% | -1.6% | |
| Q4 FY2021 | 1.44 | 1.40 | -2.78% | +4.48% | 13.33B | 13.52B | +1.46% | +3.78% | -2.6% | |
| Q3 FY2021 | 1.65 | 1.71 | +3.64% | +12.50% | 12.95B | 13.37B | +3.21% | +6.61% | +1.8% | |
| Q2 FY2021 | 1.53 | 1.66 | +8.50% | +22.96% | 12.95B | 13.29B | +2.64% | +14.39% | +0.2% | |
| Q1 FY2021 | 1.57 | 1.52 | -3.18% | -1.94% | 13.25B | 12.69B | -4.22% | -0.11% | -1.4% | |
| Q4 FY2020 | 1.38 | 1.34 | -2.90% | +2.29% | 13.22B | 13.03B | -1.45% | +2.47% | -2.6% | |
| Q3 FY2020 | 1.42 | 1.52 | +7.04% | +7.80% | 11.93B | 12.54B | +5.07% | +0.45% | -3.9% | |
| Q2 FY2020 | 1.29 | 1.35 | +4.65% | +2.27% | 11.18B | 11.62B | +3.97% | -3.34% | -2.3% | |
| Q1 FY2020 | 1.37 | 1.55 | +13.14% | +29.17% | 10.95B | 12.71B | +16.10% | +10.94% | -1.9% | |
| Q4 FY2019 | 1.32 | 1.31 | -0.76% | +5.65% | 12.42B | 12.72B | +2.38% | -6.94% | +0.2% | |
| Q3 FY2019 | 1.31 | 1.41 | +7.63% | +7.63% | 12.02B | 12.48B | +3.82% | +9.63% | +0.5% | |
| Q2 FY2019 | 1.20 | 1.32 | +10.00% | +4.76% | 10.84B | 12.02B | +10.91% | -10.62% | +4.5% | |
| Q1 FY2019 | 1.11 | 1.20 | +8.11% | -6.25% | 10.96B | 11.46B | +4.50% | -11.40% | +2.6% | |
| Q4 FY2018 | 1.33 | 1.24 | -6.77% | +3.33% | 13.98B | 13.66B | -2.29% | +3.80% | -1.1% | |
| Q3 FY2018 | 1.31 | 1.31 | 0.00% | +1.55% | 11.21B | 11.39B | +1.56% | -10.29% | +1.0% | |
| Q2 FY2018 | 1.27 | 1.26 | -0.79% | +4.13% | 13.24B | 13.45B | +1.60% | +7.67% | +2.8% | |
| Q1 FY2018 | 1.25 | 1.28 | +2.40% | +13.27% | 12.93B | 12.93B | 0.00% | +9.71% | -3.3% | |
| Q4 FY2017 | 1.16 | 1.20 | +3.45% | +7.14% | 12.94B | 13.16B | +1.71% | +4.43% | +4.9% | |
| Q3 FY2017 | 1.25 | 1.29 | +3.20% | +4.88% | 12.29B | 12.69B | +3.31% | +2.84% | -3.3% | |
| Q2 FY2017 | 1.16 | 1.21 | +4.31% | -0.82% | 12.28B | 12.49B | +1.71% | -1.46% | +1.7% | |
| Q1 FY2017 | 1.10 | 1.13 | +2.73% | -3.42% | 11.57B | 11.79B | +1.83% | -0.21% | +2.2% | |
| Q4 FY2016 | 1.09 | 1.12 | +2.75% | +0.90% | 12.61B | 12.61B | 0.00% | -1.55% | +3.0% | |
| Q3 FY2016 | 1.18 | 1.23 | +4.24% | -3.15% | 11.93B | 12.34B | +3.48% | -1.15% | -3.7% | |
| Q2 FY2016 | 1.18 | 1.22 | +3.39% | -3.17% | 12.14B | 12.68B | +4.42% | -1.68% | -0.6% | |
| Q1 FY2016 | 1.18 | 1.17 | -0.85% | -12.03% | 12.01B | 11.81B | -1.67% | -3.21% | -0.4% | |
| Q4 FY2015 | 1.22 | 1.11 | -9.02% | -8.26% | 13.78B | 12.80B | -7.09% | -4.12% | -5.4% | |
| Q3 FY2015 | 1.31 | 1.27 | -3.05% | -7.30% | 12.87B | 12.49B | -2.96% | -6.13% | -2.3% | |
| Q2 FY2015 | 1.20 | 1.26 | +5.00% | -5.97% | 12.79B | 12.90B | +0.81% | -7.55% | -2.3% | |
| Q1 FY2015 | 1.12 | 1.33 | +18.75% | +3.91% | 10.09B | 12.20B | +20.88% | -14.31% | +2.0% | |
| Q4 FY2014 | 1.13 | 1.21 | +7.08% | +0.83% | 13.35B | 13.35B | 0.00% | -13.08% | +2.5% | |
| Q3 FY2014 | 1.29 | 1.37 | +6.20% | +9.60% | 12.48B | 13.30B | +6.61% | -8.64% | +2.4% | |
| Q2 FY2014 | 1.40 | 1.34 | -4.29% | +3.08% | 14.55B | 13.95B | -4.11% | -5.13% | -1.7% | |
| Q1 FY2014 | 1.33 | 1.28 | -3.76% | -1.54% | 14.77B | 14.24B | -3.62% | +0.23% | -1.8% | |
| Q4 FY2013 | 1.22 | 1.20 | -1.64% | -5.51% | 16.22B | 15.36B | -5.26% | +1.96% | -0.4% | |
| Q3 FY2013 | 1.32 | 1.25 | -5.30% | -6.72% | 15.22B | 14.56B | -4.38% | +3.70% | +3.3% | |
| Q2 FY2013 | 1.29 | 1.30 | +0.78% | -5.80% | 14.82B | 14.70B | -0.77% | +1.12% | -0.8% | |
| Q1 FY2013 | 1.25 | 1.30 | +4.00% | +2.36% | 13.76B | 14.21B | +3.23% | +2.11% | -1.0% | |
| Q4 FY2012 | 1.27 | 1.27 | 0.00% | +3.25% | 14.06B | 15.07B | +7.21% | +0.48% | +3.4% | |
| Q3 FY2012 | 1.38 | 1.34 | -2.90% | -7.59% | 14.25B | 14.04B | -1.45% | -6.62% | -0.4% | |
| Q2 FY2012 | 1.29 | 1.38 | +6.98% | -6.76% | 13.53B | 14.54B | +7.50% | -3.85% | +1.8% | |
| Q1 FY2012 | 1.32 | 1.27 | -3.79% | -9.93% | 14.44B | 13.91B | -3.65% | -2.17% | -1.4% | |
| Q4 FY2011 | 1.20 | 1.23 | +2.50% | +7.89% | 14.62B | 15.00B | +2.56% | +3.68% | -1.2% | |
| Q3 FY2011 | 1.51 | 1.45 | -3.97% | +14.17% | 15.63B | 15.03B | -3.82% | +17.27% | -4.2% | |
| Q2 FY2011 | 1.40 | 1.48 | +5.71% | +23.33% | 14.26B | 15.12B | +6.06% | +26.86% | +2.2% | |
| Q1 FY2011 | 1.31 | 1.41 | +7.63% | -2.08% | 13.14B | 14.22B | +8.26% | +15.10% | +3.7% | |
| Q4 FY2010 | 1.25 | 1.14 | -8.80% | +12.87% | 15.74B | 14.46B | -8.09% | +10.03% | -2.9% | |
| Q3 FY2010 | 1.20 | 1.27 | +5.83% | +38.04% | 12.07B | 12.82B | +6.19% | +13.55% | -0.9% | |
| Q2 FY2010 | 1.13 | 1.20 | +6.19% | +34.83% | 11.18B | 11.92B | +6.60% | +10.98% | +0.9% | |
| Q1 FY2010 | 1.23 | 1.44 | +17.07% | +65.52% | 10.25B | 12.36B | +20.59% | +24.48% | +0.1% | |
| Q4 FY2009 | 1.10 | 1.01 | -8.18% | +53.03% | 14.22B | 13.15B | -7.56% | +27.03% | +1.7% | |
| Q3 FY2009 | 0.95 | 0.92 | -3.16% | 0.00% | 11.65B | 11.29B | -3.06% | +2.36% | +1.0% | |
| Q2 FY2009 | 0.85 | 0.89 | +4.71% | -9.18% | 10.24B | 10.74B | +4.94% | +0.15% | +2.6% | |
| Q1 FY2009 | 0.87 | 0.87 | 0.00% | -14.71% | 9.93B | 9.93B | 0.00% | -2.84% | +3.8% | |
| Q4 FY2008 | 0.79 | 0.66 | -16.46% | +65.00% | 12.05B | 10.35B | -14.13% | +1.74% | -5.1% | |
| Q3 FY2008 | 0.95 | 0.92 | -3.16% | +35.29% | 11.38B | 11.03B | -3.06% | +12.34% | +2.4% | |
| Q2 FY2008 | 0.93 | 0.98 | +5.38% | +18.07% | 10.15B | 10.73B | +5.68% | +14.11% | +1.5% | |
| Q1 FY2008 | 0.89 | 1.02 | +14.61% | +10.87% | 8.72B | 10.22B | +17.11% | +4.05% | +3.4% | |
| Q4 FY2007 | 0.73 | 0.40 | -45.21% | -42.86% | 13.29B | 10.17B | -23.48% | +9.14% | -4.2% | |
| Q3 FY2007 | 0.76 | 0.68 | -10.53% | -13.92% | 10.85B | 9.82B | -9.52% | +1.32% | +0.8% | |
| Q2 FY2007 | 0.78 | 0.83 | +6.41% | +13.70% | 8.80B | 9.40B | +6.85% | +2.37% | -2.4% | |
| Q1 FY2007 | 0.84 | 0.92 | +9.52% | +10.84% | 8.88B | 9.82B | +10.53% | +18.27% | -0.7% | |
| Q4 FY2006 | 0.78 | 0.70 | -10.26% | +20.69% | 10.27B | 9.32B | -9.30% | +6.47% | -2.5% | |
| Q3 FY2006 | 0.76 | 0.79 | +3.95% | +11.27% | 9.31B | 9.69B | +4.11% | +14.15% | +3.8% | |
| Q2 FY2006 | 0.79 | 0.73 | -7.59% | +3.69% | 9.88B | 9.18B | -7.06% | +16.67% | +0.1% | |
| Q1 FY2006 | 0.71 | 0.83 | +16.90% | — | 6.90B | 8.30B | +20.34% | — | +0.3% | |
| Q4 FY2005 | 0.71 | 0.58 | -18.31% | +3.57% | 10.36B | 8.75B | -15.48% | +15.51% | -1.6% | |
| Q3 FY2005 | 0.72 | 0.71 | -1.39% | +12.70% | 8.61B | 8.49B | -1.37% | +20.29% | +3.7% | |
| Q2 FY2005 | 0.66 | 0.70 | +6.06% | +11.11% | 7.39B | 7.34B | -0.70% | +5.28% | +2.3% | |
| Q2 FY2005 | — | 0.70 | — | +11.75% | — | 7.87B | — | +12.86% | -0.2% | |
| Q4 FY2004 | 0.60 | 0.56 | -6.67% | +1.82% | 8.08B | 7.58B | -6.25% | +12.60% | -1.3% | |
| Q3 FY2004 | 0.58 | 0.63 | +8.62% | +21.15% | 6.45B | 7.06B | +9.43% | +13.64% | +1.1% | |
| Q2 FY2004 | 0.59 | 0.63 | +6.78% | +21.15% | 6.50B | 6.97B | +7.27% | +12.41% | +5.6% | |
| Q1 FY2004 | 0.53 | 0.52 | -1.89% | +20.93% | 6.76B | 6.64B | -1.85% | +16.05% | -2.0% | |
| Q4 FY2003 | 0.53 | 0.55 | +3.77% | +22.22% | 6.48B | 6.73B | +3.92% | -13.77% | +0.1% | |
| Q3 FY2003 | 0.52 | 0.52 | 0.00% | +18.32% | 6.21B | 6.21B | 0.00% | +22.75% | +1.7% | |
| Q2 FY2003 | 0.51 | 0.52 | +1.96% | — | 6.08B | 6.20B | +2.00% | — | -1.3% | |
| Q1 FY2003 | 0.46 | 0.43 | -6.52% | — | 6.09B | 5.72B | -6.12% | — | +2.7% | |
| Q4 FY2002 | 0.42 | 0.45 | +7.14% | +11.50% | — | 7.81B | — | +51.91% | +0.8% | |
| Q3 FY2002 | 0.44 | 0.55 | +24.32% | +24.89% | — | 5.60B | — | +0.39% | -2.8% | |
| Q3 FY2002 | — | 0.44 | — | +0.34% | — | 5.06B | — | -9.27% | +0.7% | |
| Q4 FY2001 | — | 0.43 | — | +4.02% | — | 4.86B | — | +9.41% | +0.1% | |
| Q4 FY2001 | — | 0.40 | — | -2.37% | — | 5.14B | — | +15.72% | +0.3% | |
| Q3 FY2001 | — | 0.44 | — | +32.73% | — | 5.58B | — | +14.24% | -0.0% | |
| Q2 FY2001 | — | 0.40 | — | -18.07% | — | 4.31B | — | -25.75% | -0.4% | |
| Q1 FY2001 | — | 0.41 | — | — | — | 5.96B | — | — | -0.7% | |
| Q4 FY2000 | — | 0.41 | — | -15.63% | — | 4.44B | — | -22.06% | -1.3% | |
| Q3 FY2000 | — | 0.33 | — | — | — | 4.88B | — | — | +0.5% | |
| Q2 FY2000 | — | 0.49 | — | — | — | 5.81B | — | — | +1.6% | |
| Q4 FY1999 | — | 0.49 | — | — | — | 5.70B | — | — | +3.6% | |
| Q4 FY1997 | 0.56 | 0.51 | -8.93% | — | — | — | — | — | -2.0% | |
| Q2 FY1997 | 0.79 | 0.79 | 0.00% | — | — | — | — | — | +2.7% | |
| Q1 FY1997 | 0.45 | 0.52 | +15.56% | — | — | — | — | — | +0.2% |
| Period | EPS estimate | Reported EPS | Surprise | EPS growth | Revenue estimate | Reported revenue | Surprise | Revenue growth |
|---|---|---|---|---|---|---|---|---|
| FY2028 | 10.82 | — | — | +9.53% | 64.90B | — | — | +6.28% |
| FY2027 | 9.88 | — | — | +10.91% | 61.06B | — | — | +6.62% |
| FY2026 | 8.90 | — | — | -0.84% | 57.27B | — | — | +3.02% |
| FY2025 | 8.93 | 8.98 | +0.59% | +14.98% | 55.47B | 55.59B | +0.23% | +8.86% |
| FY2024 | 7.54 | 7.81 | +3.60% | +14.68% | 50.44B | 51.07B | +1.26% | +0.12% |
| FY2023 | 6.67 | 6.81 | +2.12% | +11.46% | 46.80B | 51.01B | +9.00% | -1.57% |
| FY2022 | 5.70 | 6.11 | +7.21% | -2.86% | 51.52B | 51.83B | +0.60% | -1.98% |
The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.
From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.
The outlook will show how quickly Novartis expects drug sales to recover from generic competition.
On average, analysts' EPS estimate was 5.7% off the result, either way, and their revenue estimate 2.6%, over the last 12 quarters.
See also:Forecast,EPS,Income statement
Source: Financial Modeling Prep
We value your privacy
We use cookies to enhance your experience and analyze site traffic. By continuing, you agree to our use of cookies. Privacy Policy